Literature DB >> 17581970

Dynamic changes in vesicular glutamate transporter 1 function and expression related to methamphetamine-induced glutamate release.

Karla A Mark1, Maria S Quinton, Shelley J Russek, Bryan K Yamamoto.   

Abstract

The vesicular glutamate (GLU) transporter (VGLUT1) is a critical component of glutamatergic neurons that regulates GLU release. Despite the likely role of GLU release in drug abuse pathology, there is no information that links VGLUT1 with drugs of abuse. This study provides the first evidence that methamphetamine (METH) alters the dynamic regulation of striatal VGLUT1 function and expression through a polysynaptic pathway. METH increases cortical VGLUT1 mRNA, striatal VGLUT1 protein in subcellular fractions, and the Vmax of striatal vesicular GLU uptake. METH also increases glyceraldehyde-3-phosphate dehydrogenase (GAPDH) protein in the crude vesicle fraction. METH-induced increases in cortical VGLUT1 mRNA, as well as striatal VGLUT1 and GAPDH, are GABA(A) receptor-dependent because they are blocked by GABA(A) receptor antagonism in the substantia nigra. These results show that VGLUT1 can be dynamically regulated via a polysynaptic pathway to facilitate vesicular accumulation of GLU for subsequent release after METH.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17581970      PMCID: PMC6672707          DOI: 10.1523/JNEUROSCI.0013-07.2007

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  43 in total

Review 1.  New order from neurological disorders.

Authors:  D L Price
Journal:  Nature       Date:  1999-06-24       Impact factor: 49.962

2.  Uptake of glutamate into synaptic vesicles by an inorganic phosphate transporter.

Authors:  E E Bellocchio; R J Reimer; R T Fremeau; R H Edwards
Journal:  Science       Date:  2000-08-11       Impact factor: 47.728

Review 3.  Protein synthesis in axons and its possible functions.

Authors:  R B Campenot; H Eng
Journal:  J Neurocytol       Date:  2000 Nov-Dec

Review 4.  Methamphetamine-induced dopaminergic neurotoxicity: role of peroxynitrite and neuroprotective role of antioxidants and peroxynitrite decomposition catalysts.

Authors:  S Z Imam; J el-Yazal; G D Newport; Y Itzhak; J L Cadet; W Slikker; S F Ali
Journal:  Ann N Y Acad Sci       Date:  2001-06       Impact factor: 5.691

5.  Modulation of GABA release by dopamine in the substantia nigra.

Authors:  L Matuszewich; B K Yamamoto
Journal:  Synapse       Date:  1999-04       Impact factor: 2.562

Review 6.  Complementary distribution of vesicular glutamate transporters in the central nervous system.

Authors:  Takeshi Kaneko; Fumino Fujiyama
Journal:  Neurosci Res       Date:  2002-04       Impact factor: 3.304

7.  Identification of differentiation-associated brain-specific phosphate transporter as a second vesicular glutamate transporter (VGLUT2).

Authors:  S Takamori; J S Rhee; C Rosenmund; R Jahn
Journal:  J Neurosci       Date:  2001-11-15       Impact factor: 6.167

8.  Identification of a vesicular glutamate transporter that defines a glutamatergic phenotype in neurons.

Authors:  S Takamori; J S Rhee; C Rosenmund; R Jahn
Journal:  Nature       Date:  2000-09-14       Impact factor: 49.962

9.  Immunohistochemical localization of candidates for vesicular glutamate transporters in the rat brain.

Authors:  Takeshi Kaneko; Fumino Fujiyama; Hiroyuki Hioki
Journal:  J Comp Neurol       Date:  2002-02-25       Impact factor: 3.215

10.  Differential trafficking of the vesicular monoamine transporter-2 by methamphetamine and cocaine.

Authors:  Evan L Riddle; Matthew K Topham; John W Haycock; Glen R Hanson; Annette E Fleckenstein
Journal:  Eur J Pharmacol       Date:  2002-08-02       Impact factor: 4.432

View more
  40 in total

1.  Effect of vitamin C deficiency during postnatal development on adult behavior: functional phenotype of Gulo-/- knockout mice.

Authors:  Y Chen; C P Curran; D W Nebert; K V Patel; M T Williams; C V Vorhees
Journal:  Genes Brain Behav       Date:  2012-02-02       Impact factor: 3.449

Review 2.  Matrix metalloproteinase dependent cleavage of cell adhesion molecules in the pathogenesis of CNS dysfunction with HIV and methamphetamine.

Authors:  Katherine Conant; Seung T Lim; Brad Randall; Kathleen A Maguire-Zeiss
Journal:  Curr HIV Res       Date:  2012-07       Impact factor: 1.581

3.  A neuroprotective role for microRNA miR-1000 mediated by limiting glutamate excitotoxicity.

Authors:  Pushpa Verma; George J Augustine; Mohamed-Raafet Ammar; Ayumu Tashiro; Stephen M Cohen
Journal:  Nat Neurosci       Date:  2015-02-02       Impact factor: 24.884

Review 4.  Synaptic vesicle protein trafficking at the glutamate synapse.

Authors:  M S Santos; H Li; S M Voglmaier
Journal:  Neuroscience       Date:  2008-03-22       Impact factor: 3.590

5.  The Basal Ganglia as a Substrate for the Multiple Actions of Amphetamines.

Authors:  Reka Natarajan; Bryan K Yamamoto
Journal:  Basal Ganglia       Date:  2011-07-01

6.  Methamphetamine promotes habitual action and alters the density of striatal glutamate receptor and vesicular proteins in dorsal striatum.

Authors:  Teri M Furlong; Laura H Corbit; Robert A Brown; Bernard W Balleine
Journal:  Addict Biol       Date:  2017-07-14       Impact factor: 4.280

7.  Investigating Methamphetamine Craving Using the Extinction-Reinstatement Model in the Rat.

Authors:  Peter R Kufahl; M Foster Olive
Journal:  J Addict Res Ther       Date:  2011-11-15

8.  Changes in the Prefrontal Glutamatergic and Parvalbumin Systems of Mice Exposed to Unpredictable Chronic Stress.

Authors:  Ryan Shepard; Laurence Coutellier
Journal:  Mol Neurobiol       Date:  2017-04-18       Impact factor: 5.590

9.  Glyceraldehyde-3-phosphate dehydrogenase aggregate formation participates in oxidative stress-induced cell death.

Authors:  Hidemitsu Nakajima; Wataru Amano; Takeya Kubo; Ayano Fukuhara; Hideshi Ihara; Yasu-Taka Azuma; Hisao Tajima; Takashi Inui; Akira Sawa; Tadayoshi Takeuchi
Journal:  J Biol Chem       Date:  2009-10-16       Impact factor: 5.157

10.  Metabolic Abnormalities in Abstinent Methamphetamine Dependent Subjects.

Authors:  Napapon Sailasuta; Osama Abulseoud; Martha Hernandez; Poone Haghani; Brian D Ross
Journal:  Subst Abuse       Date:  2010-04-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.